Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.887 | 30.774 |
Price to Book | 9.082 | 6.548 |
Price to Sales | 5.281 | 4.544 |
Price to Cash Flow | 23.489 | 19.187 |
Dividend Yield | 0.466 | 0.645 |
5 Years Earnings Growth | 15.683 | 14.883 |
Name | Net % | Category Average |
---|---|---|
Technology | 34.180 | 36.081 |
Healthcare | 20.530 | 15.001 |
Consumer Cyclical | 13.970 | 13.742 |
Communication Services | 12.390 | 11.357 |
Consumer Defensive | 6.270 | 4.507 |
Industrials | 6.050 | 7.997 |
Financial Services | 5.080 | 10.485 |
Basic Materials | 1.520 | 2.052 |
Number of long holdings: 55
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 9.37 | - | - | |
NVIDIA Corp | - | 7.46 | - | - | |
Amazon.com Inc | - | 6.66 | - | - | |
Meta Platforms Inc Class A | - | 5.45 | - | - | |
Alphabet Inc Class C | - | 4.75 | - | - | |
Visa Inc Class A | - | 4.34 | - | - | |
UnitedHealth Group Inc | - | 3.55 | - | - | |
Monster Beverage Corp | - | 3.18 | - | - | |
Costco Wholesale Corp | - | 2.85 | - | - | |
Vertex Pharmaceuticals Inc | - | 2.80 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Growth Portfolio C Acs | 7.85B | 13.06 | 9.86 | 14.34 | ||
Thematic Research Portfolio S SGD A | 6.44B | 8.29 | 20.72 | 12.07 | ||
American Growth Portfolio A Acs | 7.21B | -25.83 | 11.14 | 14.09 | ||
Thematic Research Portfolio S1X Acs | 2.77B | 10.14 | 21.69 | 12.12 | ||
Thematic Research Portfolio SX Accs | 3.45B | 10.51 | 22.54 | 12.86 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review